Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting

Patients with rifampicin-resistant tuberculosis (RR-TB) in the township of Khayelitsha, South Africa, were offered delamanid (DLM) within a decentralised RR-TB treatment programme. To describe adverse events (AEs) among HIV-positive and negative people receiving DLM for RR-TB in a programmatic setti...

Full description

Saved in:

Bibliographic Details
Published in:	The international journal of tuberculosis and lung disease Vol. 23; no. 9; p. 1017
Main Authors:	Hughes, J, Reuter, A, Chabalala, B, Isaakidis, P, Cox, H, Mohr, E
Format:	Journal Article
Language:	English
Published:	France 01.09.2019
Subjects:	Adolescent Adult Antitubercular Agents - administration & dosage Female Follow-Up Studies HIV Infections - epidemiology Humans Male Nitroimidazoles - administration & dosage Nitroimidazoles - adverse effects Oxazoles - administration & dosage Oxazoles - adverse effects Prevalence Rifampin - administration & dosage South Africa Tuberculosis, Multidrug-Resistant - drug therapy Young Adult South Africa
ISSN:	1815-7920, 1815-7920
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!